E-LIB Suche - Ergebnisse für: Perzborn, Elisabeth

1

Reduction of intracerebral hemorrhage by rivaroxaban after ..:

Morihara, Ryuta ; Yamashita, Toru ; Kono, Syoichiro...
Journal of Neuroscience Research. 95 (2016) 9 - p. 1818-1828 , 2016

Link: https://doi.org/10.1002/..

2

Expression of pro-inflammatory genes in human endothelial c..:

Ellinghaus, Peter ; Perzborn, Elisabeth ; Hauenschild, Peter...
Thrombosis Research. 142 (2016) - p. 44-51 , 2016

Link: https://doi.org/10.1016/..

3

Effects of Rivaroxaban on Platelet Activation and Platelet–..:

Perzborn, Elisabeth ; Heitmeier, Stefan ; Laux, Volker
Journal of Cardiovascular Pharmacology and Therapeutics. 20 (2015) 6 - p. 554-562 , 2015

Link: https://doi.org/10.1177/..

4

Reversal of rivaroxaban-induced anticoagulation with prothr..:

Perzborn, Elisabeth ; Heitmeier, Stefan ; Laux, Volker.
Thrombosis Research. 133 (2014) 4 - p. 671-681 , 2014

Link: https://doi.org/10.1016/..

5

Whole blood clots are more resistant to lysis than plasma c..:

Varin, Rémi ; Mirshahi, ShahSultan ; Mirshahi, Pezhman...
Thrombosis Research. 131 (2013) 3 - p. e100-e109 , 2013

Link: https://doi.org/10.1016/..

6

Measurement and Reversal of Prophylactic and Therapeutic Pe..:

Körber, Mareike Kristina ; Langer, Elisabeth ; Ziemer, Sabine...
Clinical and Applied Thrombosis/Hemostasis. 20 (2013) 7 - p. 735-740 , 2013

Link: https://doi.org/10.1177/..

7

Rivaroxaban: a novel oral anticoagulant for the prevention ..:

Sarich, Troy C. ; Peters, Gary ; Berkowitz, Scott D....
Annals of the New York Academy of Sciences. 1291 (2013) 1 - p. 42-55 , 2013

Link: https://doi.org/10.1111/..

8

Laboratory assessment of rivaroxaban: a review:

Samama, Meyer ; Contant, Geneviève ; Spiro, Theodore E...
Thrombosis Journal. 11 (2013) 1 - p. 11 , 2013

Link: https://doi.org/10.1186/..

9

The discovery of rivaroxaban: translating preclinical asses..:

Kubitza, Dagmar ; Perzborn, Elisabeth ; Berkowitz, Scott D.
Frontiers in Pharmacology. 4 (2013) - p. , 2013

Link: https://doi.org/10.3389/..

10

Evaluation of the Prothrombin Time for Measuring Rivaroxaba..:

Samama, Meyer Michel ; Contant, Genevieve ; Spiro, Theodore E....
Clinical and Applied Thrombosis/Hemostasis. 18 (2012) 2 - p. 150-158 , 2012

Link: https://doi.org/10.1177/..

11

Comparison of unfractionated heparin, low-molecular-weight ..:

Kaeberich, Anja ; Reindl, Iris ; Raaz, Uwe...
Journal of Thrombosis and Thrombolysis. 32 (2011) 4 - p. 417-425 , 2011

Link: https://doi.org/10.1007/..

12

A role for coagulation factor Xa in experimental pulmonary ..:

Delbeck, Martina ; Nickel, Katrin F. ; Perzborn, Elisabeth...
Cardiovascular Research. 92 (2011) 1 - p. 159-168 , 2011

Link: https://doi.org/10.1093/..

13

The discovery and development of rivaroxaban:

Misselwitz, Frank ; Berkowitz, Scott D. ; Perzborn, Elisabeth
Annals of the New York Academy of Sciences. 1222 (2011) 1 - p. 64-75 , 2011

Link: https://doi.org/10.1111/..

14

Discovery of the Novel Antithrombotic Agent 5-Chloro-N-({(5..:

Roehrig, Susanne ; Straub, Alexander ; Pohlmann, Jens...
Journal of Medicinal Chemistry. 48 (2005) 19 - p. 5900-5908 , 2005

Link: https://doi.org/10.1021/..

15

Pharmacological actions of a novel NO‐independent guanylyl ..:

Stasch, Johannes‐Peter ; Alonso‐Alija, Cristina ; Apeler, Heiner...
British Journal of Pharmacology. 135 (2002) 2 - p. 333-343 , 2002

Link: https://doi.org/10.1038/..